Meg Jardine's Publications

• Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study

  Journal articles

  2023

  American Journal of Kidney Diseases

• Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD

  Journal articles

  2023

  Clinical Journal of the American Society of Nephrology

• Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

  Journal articles

  2023

  International Journal of Cardiology

• Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study

  Journal articles

  2023

  Journal of Clinical Medicine

• Comparing survival in patients with chronic kidney disease across three countries Results from the study of heart and renal protection-extended review

  Journal articles

  2023

  Nephrology

• The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

  Preprints

  2023

• Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

  Preprints

  2023

• WCN23-1085 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATY- THE ALIGN STUDY

  Journal articles

  2023

  Kidney International Reports

• WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY

  Journal articles

  2023

  Kidney International Reports

• TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL

  Journal articles

  2023

  Journal of the American College of Cardiology

• Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID): A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

  Journal articles

  2022

  BMC Nephrology

• Digital health technologies to support medication adherence in chronic kidney disease

  Journal articles

  2022

  Nephrology

• Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program

  Journal articles

  2022

  Diabetes, Obesity and Metabolism

• Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

  Journal articles

  2022

  Trials

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  Journal articles

  2022

  The Lancet

• Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

  Journal articles

  2022

  Journal of the American College of Cardiology

• CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL

  Conference Abstracts

  2022

  NEPHROLOGY

• Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

  Journal articles

  2022

  Journal of the American Heart Association

• SGLT2 inhibitors and finerenone: one or the other or both?

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

  Journal articles

  2022

  Diabetes and Metabolism

• Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis

  Journal articles

  2022

  Clinical Kidney Journal

• Trimming the fat: Is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review

  Journal articles

  2022

  Clinical Kidney Journal

• Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial

  Journal articles

  2022

  JAMA - Journal of the American Medical Association